Long-term Therapeutic Effects of Extracorporeal Shock Wave-Assisted Melatonin Therapy on Mononeuropathic Pain in Rats

摘要

We evaluated the ability of extracorporeal shock wave (ECSW)-assisted melatonin (Mel) therapy to offer an additional benefit for alleviating the neuropathic pain (NP) in rats. Left sciatic nerve was subjected to chronic constriction injury (CCI) to induce NP. Animals (n=30) were randomized into group 1 (sham-operated control), group 2 (CCI only), group 3 (CCI+ECSW), group 4 (CCI+Mel) and group 5 (CCI+ECSW+Mel). By days 15, 22 and 29 after CCI, the thermal paw withdrawal latency (TPWL) and mechanical paw withdrawal threshold (MPWT) were highest in group 1, lowest in group 2, significantly higher in group 5 than in groups 3 and 4, but they showed no difference between the later two groups (all p<0.0001). The protein expressions of inflammatory (TNF-, NF-B, MMP-9, IL-1 ss), oxidative-stress (NOXs-1, -2, -4, oxidized protein), apoptotic (cleaved-caspase3, cleaved-PARP), DNA/mitochondrial-damaged (-H2AX/cytosolic-cytochrome C), microglia/astrocyte activation (ox42/GFAP), and MAPKs [phosphorylated (p)-p38, p-JNK, p-ERK] biomarkers in dorsal root ganglia neurons (DRGs) and in spinal dorsal horn were exhibited an opposite pattern of TPWL among the five groups (all p<0.0001). Additionally, protein expressions of Nav.1.3, Nav.1.8 and Nav.1.9 in sciatic nerve exhibited an identical pattern to inflammation among the five groups (all p<0.0001). The numbers of cellular expressions of MAPKs (p-ERK1/2+/peripherin+cells, p-ERK1/2+/NF200+cells and p-JNK+/peripherin+cells, p-JNK+/NF200+cells) and voltage-gated sodium channels (Nav.1.8+/peripherin+cells, Nav.1.8+/NF200+cells, Nav.1.9+/peripherin+cells, Nav.1.9+/NF200+cells) in small and large DRGs displayed an identical pattern to inflammation among the five groups (all p<0.0001). In conclusion, the synergistic effect of combined ECSW-Mel therapy is superior to either one alone for long-term improvement of mononeuropathic pain-induced by CCI in rats.